Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SimBioSys has demonstrated over 92% accuracy in predicting response to therapy in early breast cancer through independent clinical validation studies at leading institutions. Its TumorScope/TumorSight Viz platforms are used at top U.S. cancer centers and have received FDA clearance as a diagnostic aid for preoperative planning in breast conservation surgery. The company collaborates with more than twenty major academic medical centers and continues expanding its technology into new indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SimBioSys.